Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT00682305. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT02846376. IPD Sharing: NO. Countries: 1. Publications: 32.
Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care
ClinicalTrials.gov study NCT00023192. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
ClinicalTrials.gov study NCT03602599. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload
ClinicalTrials.gov study NCT01335035. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Feasibility of TMLI as Conditioning Regimen in Allogeneic Hematopoietic Stem-cell Transplantation
ClinicalTrials.gov study NCT06209190. IPD Sharing: NO. Countries: 1. Publications: 1.
Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
ClinicalTrials.gov study NCT06708130. IPD Sharing: NO. Countries: 1. Publications: 0.
T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation
ClinicalTrials.gov study NCT00306332. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
ClinicalTrials.gov study NCT01861106. IPD Sharing: YES. Countries: 1. Publications: 2.
Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)
ClinicalTrials.gov study NCT00422890. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML
ClinicalTrials.gov study NCT01191957. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
ClinicalTrials.gov study NCT00966810. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
ClinicalTrials.gov study NCT00060372. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation
ClinicalTrials.gov study NCT00948753. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
ClinicalTrials.gov study NCT04857645. IPD Sharing: NO. Countries: 1. Publications: 1.
Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
ClinicalTrials.gov study NCT01836068. IPD Sharing: NO. Countries: 1. Publications: 3.
Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)
ClinicalTrials.gov study NCT00962923. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
ClinicalTrials.gov study NCT02757989. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
ClinicalTrials.gov study NCT02638467. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients
ClinicalTrials.gov study NCT00599547. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.